Infectious morbidity in long-term survivors of allogeneic marrow transplantation is associated with low CD4 T cell counts
Open Access
- 1 February 1997
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 54 (2) , 131-138
- https://doi.org/10.1002/(sici)1096-8652(199702)54:2<131::aid-ajh6>3.0.co;2-y
Abstract
Survivors of allogeneic marrow transplants are immunodeficient for at least 1 year after grafting. Multiple defects of immunity have been found; however, it is not known which defect primarily accounts for the high infectious morbidity of these patients. Twenty‐nine allograft recipients who were in complete remission of the original disease were examined for the following parameters of immunity at 1 year after transplant: infection score (gauging the number and severity of infections within the 6 months prior to the annual exam), serum total IgM, IgG, and IgA, anti‐Haemophilus influenzae IgG, anti‐Streptococcus pneumoniae IgG, skin test reactivity, and the blood counts of B cells, CD4+ T cells, CD8+ T cells, and their subsets. THe only parameter inversely correlated with the infection score was CD4+ T cell count (P = 0.005 in univariable analysis, P = 0.06 in multivariable analysis). We conclude that infectious morbidity of long‐term transplant survivors is related to the reconstitution of CD4+ T cells. Am. J. Hematology 54:131–138, 1997Keywords
This publication has 37 references indexed in Scilit:
- Bacterial Pneumonia in Persons Infected with the Human Immunodeficiency VirusNew England Journal of Medicine, 1995
- Cytotoxic T-cell role in renal allograft rejection and regulation: Renal allograft infiltrating cytotoxic T-cell line with suppressor—inducer functionHuman Immunology, 1995
- The Role of the CD28 Receptor During T Cell Responses to AntigenAnnual Review of Immunology, 1993
- TREATMENT OF ACUTE GRAFT-VERSUS-HOST DISEASE WITH A NONMITOGENIC ANTI-CD3 MONOCLONAL ANTIBODYTransplantation, 1992
- Immunogenicity of Haemophilus influenzae Type b Conjugate Vaccine in Allogeneic Bone Marrow RecipientsThe Journal of Infectious Diseases, 1992
- Response to Tetanus Toxoid Immunization after Allogeneic Bone Marrow TransplantationThe Journal of Infectious Diseases, 1990
- The Risk ofPneumocystis cariniiPneumonia among Men Infected with Human Immunodeficiency Virus Type 1New England Journal of Medicine, 1990
- Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for LeukemiaNew England Journal of Medicine, 1986
- TREATMENT OF HUMAN ACUTE GRAFT-VERSUS-HOST DISEASE WITH ANTITHYMOCYTE GLOBULIN AND CYCLOSPORINE WITH OR WITHOUT METHYLPREDNISOLONETransplantation, 1985
- RECOVERY OF IN VIVO CELLULAR IMMUNITY AFTER HUMAN MARROW GRAFTINGTransplantation, 1984